TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census through three condition-focused models. Company data shared with Home Health Care News show hospitalization rates were 14.9% lower year over year from April through August 2026; the figures have not been independently verified in the source report.
Team Select Home Care says its CareSight AI platform now covers 100% of its patient census, and reports that its hospitalization rate fell 14.9% year over year from April through August 2026. The Phoenix-based provider shared the figures with Home Health Care News, but the results are company data and the report does not describe an independent evaluation.
CareSight uses more than a decade of Team Select patient records to identify changes that may signal clinical decline. The platform monitors up to eight vital signs in real time, alongside nurse notes and changes in a patient’s condition. Team Select says clinicians review alerts; the source report does not describe the platform as replacing clinical judgment.
The system expanded in stages. Team Select first developed a model for respiratory patients, then added a cardiac model and an infection-detection model. Company president and CEO Fred Johnson told Home Health Care News that the respiratory model took three years to develop, the cardiac model six months, and the infection model 90 days. The three models now cover the company’s full census, with each patient covered by at least one model.
Johnson said the initial system generated too many false positives, including alerts for readings outside general parameters that were normal for an individual patient. Team Select added patient-specific comparisons against historical baselines to help reduce those alerts. The company shared outcome data comparing April-August 2026 with the same months in 2025; the reported 14.9% figure is a year-over-year rate reduction, not a count of hospitalizations.
How Results Could Shape Payer Deals
The reported change could give Team Select evidence to use in discussions with insurers as it pursues more value-based contracts. Under those arrangements, payment can be linked to results such as fewer hospitalizations or lower total costs, rather than relying only on standard fee-for-service rates. Johnson said the company expects CareSight to help it win contracts and expand this work, but the source does not report that new contracts have been secured as a result of the data.
The model also has operational implications. Alerts that identify patient-specific changes could help care teams decide when to intervene, while excessive false alerts can add work and distract staff. Team Select says its baseline comparisons address that issue. Whether the reported reduction is sustained, and how much can be attributed specifically to CareSight rather than other changes in care, are not established by the information provided.
For patients and families, the provider’s stated aim is to support medically complex children and seniors receiving care at home and reduce avoidable trips to hospital. That potential benefit should be understood alongside the limits of the evidence: the reported outcome covers five months and comes from the company, with no independent analysis described in the report.
Products Worth Considering
Levoit Vital 100S-P Air Purifier
BowFlex Results Series SelectTech Adjustable Dumbbells (Pair)
Levoit Core 400S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
From Respiratory Care to Full Coverage
Team Select serves medically complex pediatric patients and seniors at home and operates in 16 states. Private equity firm Court Square Capital Partners invested in the company in 2023. Team Select launched CareSight in 2025, drawing on its historical patient data to build predictive models.
The first model focused on respiratory patients. According to Johnson, the company selected that group because respiratory conditions were a major area of its high-acuity work. Team Select then expanded to cardiac patients; with those two models, it said 65% of patients were covered. It developed an infection model after identifying infections as a significant source of hospitalizations in its own data. The three-model system now reaches the full census.
Johnson also cited a seven-state Medicaid claims study commissioned by Team Select before CareSight launched. He said it found the company’s monthly 30-day hospitalization rate ranged from 3% to 8%, compared with an industry average of 10% to 20% per month. Those figures are attributed to Johnson and the company-commissioned study; the source report does not provide the study’s methods or independent validation.
“I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.”
— Fred Johnson, Team Select president and CEO, speaking to Home Health Care News
Limits of the Five-Month Results
The source report provides a company-reported, five-month comparison, but does not describe an independent audit, a peer-reviewed study, or a control group. It also does not give the underlying hospitalization counts, patient numbers, statistical methods, or results by diagnosis and model. The reported year-over-year decline therefore does not establish how much of the change was caused by CareSight.
Other details remain open, including the cost of the platform, the frequency and clinical consequences of alerts, and whether the decline will continue across a longer period. The report also does not specify which value-based contracts, if any, have been signed because of the data. Team Select’s previously cited hospitalization comparisons came from a company-commissioned study, and its methods are not detailed in the material provided.
Diabetes Model and Payer Scorecards
Team Select is developing a fourth CareSight model focused on diabetes, according to the source report. It did not provide a launch date or explain which patients the model will cover. The company has also been redeveloping payer scorecards that Johnson said would show measures such as patient Net Promoter Scores, hospitalization rates, and emergency department visit ratios, with comparisons to industry averages.
The next evidence to watch includes whether Team Select publishes results over a longer period, provides more detail on how the hospitalization rate was calculated, and reports whether payers adopt contracts tied to the outcomes. Until then, the expansion and the 14.9% reduction remain developments and results reported by the company.
Key Questions
What did Team Select announce?
Team Select says its CareSight AI platform now covers 100% of its patient census through respiratory, cardiac, and infection-focused models.
How much did hospitalizations fall?
The company reported a 14.9% year-over-year reduction in its hospitalization rate from April through August 2026, compared with the same period in 2025.
Has the reported reduction been independently verified?
The source report attributes the figures to Team Select and does not describe an independent audit, control group, or external evaluation. The result should be treated as company-reported data.
What does CareSight monitor?
Team Select says the platform uses historical patient records, monitors up to eight vital signs in real time, and considers nurse notes and changes in condition to generate alerts.
What is Team Select developing next?
The company is building a fourth model focused on diabetes and redeveloping payer scorecards. The source does not give a release date for either initiative.
Source: rss
